Live Analyst Rating Changes 1505 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ann Hynes
MIZU
Ann Hynes
Mizuho Securities
Wall Street Analyst
★★★★☆
#293
on 13Foresight · ranked by our own returns
67%
Success Rate
+5.6%
Average Return
26 of 39 calls profitable · +0.9% vs benchmark
📈 Across the calls we could measure, roughly 67% of Ann Hynes's ratings turned a profit when each position was held for 1 year — averaging +5.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

112 Buy 32 Hold 0 Sell
Ann's Stock Coverage 32 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
CNC
Centene
 Jun 08, 2026 HOLD Buy
+8.9% avg upside
28 analysts
$63.00
3.91% Upside
 -6.8%
ELV
Elevance Health
 Jun 08, 2026 BUY Strong Buy
+10.2% avg upside
32 analysts
$465.00
18.90% Upside
 -6.7%
UNH
UnitedHealth
 Jun 08, 2026 BUY Strong Buy
+2.5% avg upside
35 analysts
$460.00
15.07% Upside
 +0.8%
MOH
Molina Healthcare
 Jun 08, 2026 BUY Buy
+13.8% avg upside
25 analysts
$215.00
9.87% Upside
 +0.9%
HUM
Humana
 Jun 08, 2026 BUY Buy
-11.8% avg upside
34 analysts
$390.00
7.71% Upside
 +1.7%
CVS
CVS Health
 Jun 08, 2026 BUY Strong Buy
+2.5% avg upside
38 analysts
$115.00
15.97% Upside
 +3.8%
CI
Cigna
 Jun 08, 2026 BUY Strong Buy
+21.9% avg upside
29 analysts
$340.00
19.23% Upside
 -1.1%
ACHC
Acadia Healthcare
 May 19, 2026 HOLD Strong Buy
+64.0% avg upside
17 analysts
$27.00
14.85% Upside
 +0.3%
SEM
Select Medical
 May 12, 2026 HOLD Buy
+28.0% avg upside
9 analysts
$16.50
0.38% Downside
 +1.7%
FTRE
Fortrea Holdings Inc.
 May 12, 2026 HOLD Buy
-3.5% avg upside
11 analysts
$13.00
15.18% Downside
 -8.2%
CRL
Charles River Labs
 May 08, 2026 HOLD Strong Buy
+13.1% avg upside
34 analysts
$192.00
5.35% Upside
 +5.6%
CON
Concentra Group Holdings Parent, Inc.
 May 08, 2026 BUY Strong Buy
+10.4% avg upside
9 analysts
$30.00
5.61% Upside
 +7.7%
MD
Pediatrix Medical Group
 May 08, 2026 HOLD Buy
-10.7% avg upside
14 analysts
$24.00
1.81% Upside
 -0.1%
BTSG
BrightSpring Health Services, Inc.
 May 05, 2026 BUY Strong Buy
-14.6% avg upside
18 analysts
$61.00
5.39% Downside
 +25.2%
UHS
Universal Health
 Apr 29, 2026 BUY Buy
+50.2% avg upside
22 analysts
$230.00
62.84% Upside
 -15.8%
MEDP
Medpace Holdings
 Apr 24, 2026 BUY Buy
-11.5% avg upside
16 analysts
$495.00
8.35% Upside
 +13.8%
ICLR
Icon
 Apr 09, 2026 BUY Strong Buy
+26.2% avg upside
25 analysts
$180.00
25.55% Upside
 +38.4%
THC
Tenet Healthcare
 Mar 12, 2026 BUY Strong Buy
+22.3% avg upside
26 analysts
$265.00
48.48% Upside
 -20.6%
SGRY
Surgery Partners
 Mar 05, 2026 BUY Strong Buy
+72.0% avg upside
18 analysts
$17.00
19.38% Upside
 +7.3%
HCA
HCA Healthcare
 Feb 25, 2026 BUY Buy
+11.5% avg upside
35 analysts
$585.00
50.63% Upside
 -28.3%
IQV
IQVIA Holdings
 Feb 23, 2026 BUY Strong Buy
+33.0% avg upside
38 analysts
$215.00
25.91% Upside
 +9.9%
LH
Labcorp Holdings
 Feb 18, 2026 BUY Strong Buy
+0.7% avg upside
36 analysts
$320.00
23.29% Upside
 -7.8%
DGX
Quest Diagnostics
 Feb 12, 2026 BUY Buy
-13.1% avg upside
33 analysts
$235.00
18.82% Upside
 -1.0%
EHC
Encompass Health
 Feb 09, 2026 BUY Strong Buy
+13.6% avg upside
22 analysts
$134.00
36.95% Upside
 -7.6%
ARDT
Ardent Health Partners, Inc.
 Dec 18, 2025 BUY Buy
+50.2% avg upside
16 analysts
$12.00
32.06% Upside
 +1.7%
COR
Cencora
 Mar 07, 2025 BUY Buy
+13.1% avg upside
43 analysts
 — +41.8%
MCK
McKesson
 Nov 06, 2024 HOLD Strong Buy
-4.5% avg upside
27 analysts
 — +57.0%
CAH
Cardinal Health
 Nov 04, 2024 HOLD Strong Buy
-13.9% avg upside
29 analysts
$110.00
51.44% Downside
 +77.1%
TFX
Teleflex
 Nov 08, 2022 HOLD Buy
+44.0% avg upside
19 analysts
$220.00
76.05% Upside
 +0.4%
MA
Mastercard
 Sep 12, 2022 BUY Strong Buy
+17.4% avg upside
52 analysts
 — +23.8%
CMS
CMS Energy
 Apr 11, 2022 BUY Strong Buy
+5.9% avg upside
21 analysts
 — -12.0%
CYH
Community Health
 Jul 27, 2018 HOLD Sell
+45.4% avg upside
18 analysts
$3.60
19.96% Upside
 -31.1%
🔒 27 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ann Hynes — Frequently Asked Questions
How accurate are Ann Hynes's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Ann's ratings were profitable over a one-year hold, with an average return of +5.6% per rating, or +0.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ann ranked on 13Foresight?
Ann Hynes is currently ranked #293 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ann cover?
Ann most recently has ratings on CNC, ELV, UNH, MOH, HUM, CVS, CI, ACHC, SEM, FTRE, CRL, CON and 20 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.